In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media:: Studies of native AML blasts and AML cell lines

被引:59
作者
Bruserud, O [1 ]
Gjertsen, BT
Von Volkman, HL
机构
[1] Haukeland Univ Hosp, Dept Med, Inst Med, Div Hematol, N-5021 Bergen, Norway
[2] Univ Bergen, Bergen, Norway
来源
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 2000年 / 9卷 / 06期
关键词
D O I
10.1089/152581600750062372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The functional characteristics were compared for acute myelogenous leukemia (AML) cells (native blasts and AML cell lines) cultured in three serum-free media (X-vivo 10(R), X-vivo 15(R), [BioWhitacker, Walkersville, MD] and StemSpan(TM) [Stem Cel Technologies, Vancouver, BC, Canada]) and in medium containing 10% inactivated fetal calf serum (FCS). For native AML blasts the following functions were compared: (1) autonomous and cytokine-dependent proliferation; (2) frequency of clonogenic cell; and (3) constitutive cytokine secretion, AML blast proliferation differed between patients independent of the culture medium used, and clonogenic cells were maintained after in vitro culture in all media. In contrast, constitutive cytokine secretion was higher for cells cultured in StemSpan(TM) and FCS-containing medium than for cells cultured in the X-vivo(R) media. Native AML blasts incubated in StemSpan(TM) also showed a low frequency of apoptotic cells. The three serum-free media could also be used for long-term expansion of well-characterized AML cell lines, but the optimal medium for cell expansion and cytokine secretion differed between cell lines. We conclude that standardized serum-free culture conditions can be used for in vitro studies of native AML blasts and AML cell lines.
引用
收藏
页码:923 / 932
页数:10
相关论文
共 24 条
  • [1] BLOCH A, 1993, LEUKEMIA, V7, P1219
  • [2] In vitro culture of acute myelogenous leukemia blasts: A comparison of four different culture media
    Bruserud, O
    Frostad, S
    Foss, B
    [J]. JOURNAL OF HEMATOTHERAPY, 1999, 8 (01): : 63 - 73
  • [3] Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies
    Bruserud, O
    [J]. LEUKEMIA, 1999, 13 (08) : 1175 - 1187
  • [4] Bruserud O, 1998, CYTOKINES CELL MOL T, V4, P187
  • [5] Bruserud O, 1996, LEUKEMIA, V10, P1497
  • [6] BRUSERUD O, 1995, LEUKEMIA, V9, P1910
  • [7] Effects of γ-irradiation on acute myelogenous leukemia blasts:: In vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation
    Bruserud, O
    Ulvestad, E
    [J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 1999, 8 (04): : 431 - 441
  • [8] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial
    Burnett, AK
    Goldstone, AH
    Stevens, RMF
    Hann, IM
    Rees, JKH
    Gray, RG
    Wheatley, K
    [J]. LANCET, 1998, 351 (9104) : 700 - 708
  • [9] Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
    Cassileth, PA
    Harrington, DP
    Appelbaum, FR
    Lazarus, HM
    Rowe, JM
    Paietta, E
    Willman, C
    Hurd, DD
    Bennett, JM
    Blume, KG
    Head, DR
    Wiernik, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) : 1649 - 1656
  • [10] CHANG J, 1986, LANCET, V1, P294